Neoadjuvant chemotherapy may greatly benefit HR+ BC patients with BRCA1 mutationOctober 18, 2023Breast Cancer
Alpelisib therapy associated with high hyperglycemia risk in BC standard careOctober 18, 2023Breast Cancer
Chemo-free dalpiciclib + pyrotinib regimen shows promise in HER2+ advanced BC patients in phase 2October 18, 2023Breast Cancer
Hypofractionated and conventional fractionated proton PMRT show comparable tolerability in breast cancerOctober 18, 2023Breast Cancer
Male patients with breast cancer: Special considerations and gender-specific concernsOctober 13, 2023Breast Cancer
Does surgery improve survival in metastatic breast cancer?October 9, 2023Metastatic Breast CancerBreast Cancer
‘Reassuring’ follow-up validates radiation strategy for early breast cancerOctober 6, 2023Breast Cancer
Adopting high-dose radiation vs. conventional after mastectomy could be ‘game changer’October 4, 2023Breast Cancer
Omitting sentinel lymph node biopsy safe for some early breast cancersSeptember 26, 2023Breast Cancer
